Clinical Trial Update: A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial of a hemp-derived cannabidiol product for anxiety was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Cannabidiol (hemp-derived CBD) product (cannabidiol)

Snippet

Sponsor: Mclean Hospital | Conditions: Anxiety | Phase 2 | Status: TERMINATED | Results posted: 2024-08-27